EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 1,500.00
+17.00 (1.15%)
At close: Jul 21, 2026
EyeGene Market Cap
EyeGene has a market cap or net worth of 64.84 billion as of July 21, 2026. Its market cap has decreased by -30.86% in one year.
Market Cap
64.84B
Enterprise Value
22.71B
Revenue
4.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,500.00
ChartMarket Cap Chart
Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 64.84B, a decrease of -50.50%. That is a compound annual growth rate of -6.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 64.84B | -13.74% |
| Dec 30, 2025 | 75.18B | 8.64% |
| Dec 30, 2024 | 69.20B | -24.46% |
| Dec 28, 2023 | 91.61B | -15.21% |
| Dec 29, 2022 | 108.04B | -73.58% |
| Dec 30, 2021 | 408.92B | 175.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 79.01B |
| BIO-FD&C | 72.78B |
| SunBio,Inc. | 69.75B |
| QuadMedicine | 68.89B |
| CTCBIO | 67.90B |
| AriBioLab | 64.05B |
| KoBioLabs | 63.40B |
| PanGen Biotech | 61.69B |